Sentences with phrase «ovarian cancer risk in»

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Diet May Play Role in Lowering Ovarian Cancer Risk in African - American Women LifeScienceDaily.com — September 27, 2016

The ovarian cancer risk in BRCA1 mutation carriers by age 70 years is 34 % overall but decreases to 26 % (95 % CI, 10 % -43 %) among women who carry a founder mutation.

Not exact matches

«Color's $ 99 BRCA Test, the most affordable genetic test for BRCA1 and BRCA2 ever on the market, is now available to any woman who wants to take the first step toward learning her risk for hereditary breast and ovarian cancer,» said the company in a blog post.

Genetic testing startup Color Genomics announced Monday that it would be making genetic tests for BRCA1 and BRCA2, whose mutations significantly increase the risk for breast or ovarian cancer in women who carry them, available commercially for $ 99.

According to the authors, Australian researchers Kara Britt and Roger Short, there are about 95,000 nuns in the world, and they are paying «a terrible price for their chastity»: increased risks of breast, ovarian and uterine cancer.

Constant ovulation is not normal nor healthy for their bodies and increases their risk for ovarian cancer, uterine prolapse and other reproductive diseases causing early death (which is why they are sent to slaughter for cheap meat in the egg industry).

For mothers, breastfeeding has been correlated with a significant decrease in the risk of diseases such as breast cancer, ovarian cancer, diabetes, and heart disease to name just a few.

For women who choose to breastfeed there are lower risks associated with breast and ovarian cancer, less chance of hip fractures and osteoporosis in later life, and the added benefit that it helps with getting back to their pre-baby weight.

There have also been claims that when talcum powder is used by women in the genital area it raises the risk of ovarian cancer.

For mom too, there are apparent benefits - breastfeeding has been linked to a decrease in the risk for breast and ovarian cancers, and protection against osteoporosis.

In ovarian cancer, breastfeeding for 12 - 24 months significantly reduces the risk by one - third.

Moms who breastfeed for a total of 12 months through their life or participate in extended breastfeeding for their baby's first year of life or longer may have a decreased risk of developing breast or ovarian cancer, heart disease, diabetes, rheumatoid arthritis, and other diseases.

Recent research demonstrates that lactating women have an earlier return to prepregnant weight, 41 delayed resumption of ovulation with increased child spacing,42 - 44 improved bone remineralization postpartum45 with reduction in hip fractures in the postmenopausal period, 46 and reduced risk of ovarian cancer47 and premenopausal breast cancer.48

Maternal benefits of breastfeeding have been established in the realm of better postpartum recovery and decreased risk of long - term obesity, osteoporosis and breast and ovarian cancer.

For the mother, benefits include a more rapid involution of the uterus, return to pre-pregnancy weight; and a reduction in postpartum blood loss and a lifetime risk of developing cardiovascular disease, breast cancer, ovarian cancer, and rheumatoid arthritis2.

Part of my mission is to share information about ovarian cancer with women in order to help them understand the risk factors, symptoms and precautions to promote early detection and reduce ovarian cancer related deaths.

Plus, breastfeeding encourages quicker bonding between mother and baby, easier weight loss for mom, lowered risk of post partum depression and lowered risk for breast and ovarian cancers in mothers.

lower risk of ovarian cancer, as does having used birth control at any point in your life.

And selfishly, my risk for breast and ovarian cancers later in life are decreased due to breastfeeding.

Important health benefits of breastfeeding and lactation are also described for mothers.83 The benefits include decreased postpartum bleeding and more rapid uterine involution attributable to increased concentrations of oxytocin, 84 decreased menstrual blood loss and increased child spacing attributable to lactational amenorrhea, 85 earlier return to prepregnancy weight, 86 decreased risk of breast cancer, 87 — 92 decreased risk of ovarian cancer, 93 and possibly decreased risk of hip fractures and osteoporosis in the postmenopausal period.94 — 96

Full - term breast feedings further reduces the mother's risk developing breast ovarian and uterine cancers as well as reducing the risk of osteoporosis later in life.

Breastfeeding also enhances the bond between mother and child, is cost - free and convenient, and can reduce the risk of some health problems in women like ovarian cancer.

Some studies suggest it may help prevent bone loss later in life and possibly lower the risk of ovarian cancer by delaying the onset of menstruation after pregnancy.

«Healthy diet may reduce risk of ovarian cancer in African - American women.»

Using genome data from more than 50,000 cancer cases and 60,000 controls through the GAME - ON (Genetic Associations and Mechanisms in Oncology) network, the team compared telomere lengths with the risk of developing breast, lung, colorectal, ovarian and prostate cancers, including subtypes.

In order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United StateIn order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Statein African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United SCancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer in African - American women in 11 sites in the United Statein African - American women in 11 sites in the United Statein 11 sites in the United Statein the United States.

About a quarter of patients had mutations in the DNA repair genes including BRCA1 or BRCA2 genes, which are known to increase the risk of breast and ovarian cancer.

The ACMG working group limited its list to genes that carry a high risk of disease — for example, mutations in BRCA1 and BRCA2, which significantly raise the risk of breast and ovarian cancer, and for which extra screening and prophylactic surgery can reduce risk.

Razqallah Hakem, a cancer biologist at the University of Toronto in Ontario, and his colleagues normally study a tumor suppressor called BRCA1, variants of which put women at high risk of breast and ovarian cancer.

«Women who carry a mutation in BRCA genes have an increased risk of developing breast and ovarian cancer,» Kristy A. Brown, Ph.D., study principal investigator, said.

Nursing improves bone strength (leading to fewer hip fractures in postmenopausal women) and reduces the risk of ovarian cancer and premenopausal breast cancer.

«We know that patients with BRCA mutations are at high risk for developing breast, as well as pancreatic, ovarian, prostate and other cancers, and we have learned over time that BRCA plays a very important role in DNA damage repair.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DieOvarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diegcancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Research Annual Meeting in San Diego, CA.

Variations in a woman's genome may contribute to her risk of developing ovarian cancer.

The role of weight in ovarian - cancer risk emerges from an analysis of data on some 68,000 women participating in one of three major ongoing investigations: the New York (City) University Women's Health Study, the Northern Sweden Health and Disease Study in Umea, and the Diet in the Etiology of Breast Cancer Study in Milan, cancer risk emerges from an analysis of data on some 68,000 women participating in one of three major ongoing investigations: the New York (City) University Women's Health Study, the Northern Sweden Health and Disease Study in Umea, and the Diet in the Etiology of Breast Cancer Study in Milan, Cancer Study in Milan, Italy.

Where mutations occur in two important cancer genes can affect a woman's risk of breast or ovarian cancer, a study of thousands of women shows.

Researchers from Haukeland University Hospital in Bergen, Norway, and colleagues analyzed for potential impact of normal tissue BRCA1 methylation on ovarian cancer risk.

Changes in this gene are associated with a high risk of developing breast and ovarian cancer.

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer.

Should the results be confirmed by further studies, it is possible that patients with certain genetic changes in BRCA1 could be identified as being at higher risk of breast and ovarian cancer.

By comparison, the lifetime risk of ovarian cancer in all women (including those without BRCA mutations) is only 1.4 percent.

For example, eight children with leukemia or other cancers had mutations in genes that dramatically raise risk of breast and ovarian cancer in adults — the BRCA genes and PALB2.

The USPSTF recommendation statement follows a review of evidence on the benefits and harms of screening for ovarian cancer in asymptomatic women not known to be at high risk for ovarian cancer.

Dr James Brenton, Cancer Research UK's ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save Cancer Research UK's ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save lives.

When Lisbeth Ceriani, a 43 - year - old Massachusetts woman, was diagnosed with breast cancer last year, her doctors recommended that she undergo genetic testing to see if she carried mutations in the BRCA1 and BRCA2 genes that increase risk of breast and ovarian cancers.

«We are currently waiting for the results of a larger, randomized study currently being conducted in the United Kingdom that uses the same Risk of Ovarian Cancer Algorithm in a similar population of women.

«The results from our study are not practice - changing at this time; however, our findings suggest that using a longitudinal (or change over time) screening strategy may be beneficial in post-menopausal women with an average risk of developing ovarian cancer,» said Dr. Lu.

Based on a calculation called the «Risk of Ovarian Cancer Algorithm,» women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high riRisk of Ovarian Cancer Algorithm,» women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high ririsk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high ririsk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high riskrisk).